RaySearch Laboratories AB (publ) (OTCPK:RSLBF) Q3 2025 Earnings Call November 7, 2025 4:00 AM EST Company Participants Carolina Stromlid - Head of Investor Relations Johan Löf - Founder, CEO, President & Director Nina Grönberg Conference Call Participants Mattias Vadsten - SEB, Research Division Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division Presentation Carolina Stromlid Head of Investor Relations Good morning and a warm welcome to the presentation of RaySearch Q3 2025 Results. My name is Carolina Stromlid and I'm new Head of Investor Relations at RaySearch.
| Insurance Industry | Financials Sector | Dr. Johan Lof CEO | OTC PINK Exchange | SE0000135485 ISIN |
| Sweden Country | 375 Employees | 23 May 2025 Last Dividend | 25 Jun 2008 Last Split | - IPO Date |
RaySearch Laboratories AB (publ), headquartered in Stockholm, Sweden, is a pioneering medical technology company that specializes in developing advanced software solutions aimed at improving cancer treatment. The company operates across a broad geographical range, including the Asia-Pacific, the Middle East, the Americas, Europe, and Africa. RaySearch's commitment to innovation is reflected in its focus on creating and marketing cutting-edge treatment planning systems, oncology information systems, and other specialized software platforms designed to support the complex processes involved in radiation therapy, ensuring more effective and personalized cancer care.
In addition to these innovative software solutions, RaySearch Laboratories AB (publ) is committed to the continuous education of its clients, offering an array of training courses related to its products. Through these offerings, RaySearch empowers healthcare professionals with knowledge and tools to achieve excellence in cancer treatment and care.